15th World Bispecific Summit 2024
Evvnt Promotion / evvnt
03.09.2024 - 05.09.2024 The Royal Sonesta Boston, 40 Edwin H Land Boulevard, 02142 Cambridge, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Conference themes
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URLs:
Brochure: https://go.evvnt.com/2403858-3?pid=4832
Twitter: https://go.evvnt.com/2403858-4?pid=4832
LinkedIn: https://go.evvnt.com/2403858-5?pid=4832
URLs:
Brochure: https://go.evvnt.com/2403858-3?pid=4832
Twitter: https://go.evvnt.com/2403858-4?pid=4832
LinkedIn: https://go.evvnt.com/2403858-5?pid=4832
Enquiries and Registration:
https://go.evvnt.com/2403858-2?pid=4832
Ms. Abigail Cox
Oncology
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
